Long-term outcome of patients with Marfan syndrome with previous aortic surgery but native aortic roots.


Journal

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
ISSN: 1873-734X
Titre abrégé: Eur J Cardiothorac Surg
Pays: Germany
ID NLM: 8804069

Informations de publication

Date de publication:
01 12 2020
Historique:
received: 30 12 2019
revised: 06 05 2020
accepted: 09 05 2020
pubmed: 20 9 2020
medline: 22 6 2021
entrez: 19 9 2020
Statut: ppublish

Résumé

The goal of this study was to report the long-term outcomes of patients with Marfan syndrome who had aortic surgery on any aortic segment except for the replacement of the aortic root itself. An observational retrospective single-centre study was conducted with 115 Marfan syndrome patients who underwent 189 major aortic interventions from 1995 until 2018. Patients without aortic root replacement were identified and aortic root growth was analysed over time. Eleven of 115 patients (9.5%) did not have aortic root replacement during a follow-up of 10.5 [standard deviation (SD) 5.7] years and a mean age at last follow-up of 53.9 (SD 13.4) years. Patients without root replacement did not suffer less frequently from any type of acute aortic dissection (type A 27% vs 25%, P = 0.999; type B 36% vs 25%, P = 0.474). Patients with native aortic roots did not undergo fewer aortic interventions than those with aortic root replacement [12/11, mean 1.09 (SD 0.54) operations/patient vs 177/104, mean 1.7 (SD 1.3); P = 0.128]. Progression of the aortic root dimension was 0.5 (SD 0.3) mm/year in the group of patients with native aortic roots. Current data suggest that 10% of patients with Marfan syndrome with previous aortic surgery will be free from aortic root replacement until the sixth decade of life.

Identifiants

pubmed: 32949138
pii: 5908797
doi: 10.1093/ejcts/ezaa221
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1289-1295

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Auteurs

Selim Mosbahi (S)

Department of Cardiovascular Surgery, University Hospital Bern, Bern, Switzerland.

Murat Yildiz (M)

Department of Cardiovascular Surgery, University Hospital Bern, Bern, Switzerland.

Paul-Philipp Heinisch (PP)

Department of Cardiovascular Surgery, University Hospital Bern, Bern, Switzerland.

Bettina Langhammer (B)

Department of Cardiovascular Surgery, University Hospital Bern, Bern, Switzerland.

Silvan Jungi (S)

Department of Cardiovascular Surgery, University Hospital Bern, Bern, Switzerland.

Thierry P Carrel (TP)

Department of Cardiovascular Surgery, University Hospital Bern, Bern, Switzerland.

Florian S Schoenhoff (FS)

Department of Cardiovascular Surgery, University Hospital Bern, Bern, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH